85 related articles for article (PubMed ID: 30478786)
1. ANXA2 expression in African American triple-negative breast cancer patients.
Gibbs LD; Chaudhary P; Mansheim K; Hare RJ; Mantsch RA; Vishwanatha JK
Breast Cancer Res Treat; 2019 Feb; 174(1):113-120. PubMed ID: 30478786
[TBL] [Abstract][Full Text] [Related]
2. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
[TBL] [Abstract][Full Text] [Related]
3. Identifying Biomarkers Using Support Vector Machine to Understand the Racial Disparity in Triple-Negative Breast Cancer.
Sahoo B; Pinnix Z; Sims S; Zelikovsky A
J Comput Biol; 2023 Apr; 30(4):502-517. PubMed ID: 36716280
[TBL] [Abstract][Full Text] [Related]
4. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study.
Yaghoobi V; Moutafi M; Aung TN; Pelekanou V; Yaghoubi S; Blenman K; Ibrahim E; Vathiotis IA; Shafi S; Sharma A; O'Meara T; Fernandez AI; Pusztai L; Rimm DL
Breast Cancer Res; 2021 Dec; 23(1):113. PubMed ID: 34906209
[TBL] [Abstract][Full Text] [Related]
6. Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort.
Martini R; Chen Y; Jenkins BD; Elhussin IA; Cheng E; Hoda SA; Ginter PS; Hanover J; Zeidan RB; Oppong JK; Adjei EK; Jibril A; Chitale D; Bensenhaver JM; Awuah B; Bekele M; Abebe E; Kyei I; Aitpillah FS; Adinku MO; Ankomah K; Osei-Bonsu EB; Nathansan SD; Jackson L; Jiagge E; Petersen LF; Proctor E; Nikolinakos P; Gyan KK; Yates C; Kittles R; Newman LA; Davis MB
Sci Rep; 2021 Apr; 11(1):9247. PubMed ID: 33927264
[TBL] [Abstract][Full Text] [Related]
7. Analysis of gene expression profiles to elucidate racial differences in African American and White patients with Triple-negative breast cancer.
McAndrew H; Rigler J; Yeguvapalli S; Chitrala KN
bioRxiv; 2024 Jun; ():. PubMed ID: 38853921
[TBL] [Abstract][Full Text] [Related]
8. Annexin A2 in Inflammation and Host Defense.
Dallacasagrande V; Hajjar KA
Cells; 2020 Jun; 9(6):. PubMed ID: 32575495
[TBL] [Abstract][Full Text] [Related]
9. Correction to: Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
Breast Cancer Res; 2020 Mar; 22(1):31. PubMed ID: 32293512
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers.
Kim H; Wisniewska K; Regner MJ; Thennavan A; Spanheimer PM; Franco HL
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685859
[TBL] [Abstract][Full Text] [Related]
11. Landmark Series: The Cancer Genome Atlas and the Study of Breast Cancer Disparities.
Johnson JA; Moore BJ; Syrnioti G; Eden CM; Wright D; Newman LA
Ann Surg Oncol; 2023 Oct; 30(11):6427-6440. PubMed ID: 37587359
[TBL] [Abstract][Full Text] [Related]
12. Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer.
Desai PP; Narra K; James JD; Jones HP; Tripathi AK; Vishwanatha JK
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612209
[TBL] [Abstract][Full Text] [Related]
13. KIFC1: A Reliable Prognostic Biomarker in Rb-positive Triple-negative Breast Cancer Patients Treated With Doxorubicin in Combination With Abemaciclib.
Fleisher B; Werkman C; Jacobs B; Varkey J; Taha K; Ait-Oudhia S
Cancer Diagn Progn; 2022; 2(5):525-532. PubMed ID: 36060015
[TBL] [Abstract][Full Text] [Related]
14. [CCL18 Promotes the Invasion of Lung Adenocarcinoma through ANXA2].
Deng Z; Xiao Q; Zheng Y; Feng R; Sheng Z; Zhang B
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):461-467. PubMed ID: 34120429
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients.
Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917
[TBL] [Abstract][Full Text] [Related]
16. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis
Qiu LW; Liu YF; Cao XQ; Wang Y; Cui XH; Ye X; Huang SW; Xie HJ; Zhang HJ
World J Gastroenterol; 2020 May; 26(18):2126-2137. PubMed ID: 32476780
[TBL] [Abstract][Full Text] [Related]
17. Annexin 2 protein expression is associated with breast cancer subtypes in African American women.
Beyene DA; Kanarek NF; Naab TJ; Ricks-Santi LL; Hudson TS
Heliyon; 2020 Feb; 6(2):e03241. PubMed ID: 32072035
[TBL] [Abstract][Full Text] [Related]
18. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
